These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 18812535

  • 1. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Singh S, Loke YK, Furberg CD.
    JAMA; 2008 Sep 24; 300(12):1439-50. PubMed ID: 18812535
    [Abstract] [Full Text] [Related]

  • 2. Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence.
    Salpeter SR.
    Drugs; 2009 Oct 22; 69(15):2025-33. PubMed ID: 19791824
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: systematic review with meta-analysis.
    Rodrigo GJ, Castro-Rodriguez JA, Nannini LJ, Plaza Moral V, Schiavi EA.
    Respir Med; 2009 Oct 22; 103(10):1421-9. PubMed ID: 19556116
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cardiovascular safety of tiotropium in patients with COPD.
    Celli B, Decramer M, Leimer I, Vogel U, Kesten S, Tashkin DP.
    Chest; 2010 Jan 22; 137(1):20-30. PubMed ID: 19592475
    [Abstract] [Full Text] [Related]

  • 7. The use of inhaled anticholinergics in chronic obstructive pulmonary disease: is there cause for concern of cardiovascular safety?
    McIvor RA.
    Pol Arch Med Wewn; 2009 Nov 22; 119(11):697-8. PubMed ID: 19920792
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Are there cardiovascular adverse effects of inhaled anticholinergics?].
    Nagy LB.
    Orv Hetil; 2015 Aug 02; 156(31):1246-52. PubMed ID: 26211748
    [Abstract] [Full Text] [Related]

  • 10. Inhaled beta-2-agonists/muscarinic antagonists and acute myocardial infarction in COPD patients.
    Rottenkolber M, Rottenkolber D, Fischer R, Ibáñez L, Fortuny J, Ballarin E, Sabaté M, Ferrer P, Thürmann P, Hasford J, Schmiedl S.
    Respir Med; 2014 Aug 02; 108(8):1075-90. PubMed ID: 24950946
    [Abstract] [Full Text] [Related]

  • 11. Anticholinergic treatment in airways diseases.
    Flynn RA, Glynn DA, Kennedy MP.
    Adv Ther; 2009 Oct 02; 26(10):908-19. PubMed ID: 19967500
    [Abstract] [Full Text] [Related]

  • 12. Risk of major adverse cardiovascular events with inhaled anticholinergics in patients with chronic obstructive pulmonary disease.
    Covelli HD.
    JAMA; 2009 Mar 25; 301(12):1223; author reply 1225-6. PubMed ID: 19318645
    [No Abstract] [Full Text] [Related]

  • 13. Risk of major adverse cardiovascular events with inhaled anticholinergics in patients with chronic obstructive pulmonary disease.
    Kesten S, Leimer I, Jara M.
    JAMA; 2009 Mar 25; 301(12):1224; author reply 1225-6. PubMed ID: 19318648
    [No Abstract] [Full Text] [Related]

  • 14. Risk of major adverse cardiovascular events with inhaled anticholinergics in patients with chronic obstructive pulmonary disease.
    Oba Y.
    JAMA; 2009 Mar 25; 301(12):1223; author reply 1225-6. PubMed ID: 19318646
    [No Abstract] [Full Text] [Related]

  • 15. Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease.
    Panning CA, DeBisschop M.
    Pharmacotherapy; 2003 Feb 25; 23(2):183-9. PubMed ID: 12587807
    [Abstract] [Full Text] [Related]

  • 16. Tiotropium: a potential replacement for ipratropium in patients with COPD.
    Shukla VK.
    Issues Emerg Health Technol; 2002 Jul 25; (35):1-4. PubMed ID: 12195603
    [Abstract] [Full Text] [Related]

  • 17. Risk of major adverse cardiovascular events with inhaled anticholinergics in patients with chronic obstructive pulmonary disease.
    Hodgin KE, Maloney JP.
    JAMA; 2009 Mar 25; 301(12):1224; author reply 1225-6. PubMed ID: 19318647
    [No Abstract] [Full Text] [Related]

  • 18. How safe are anticholinergics in patients with COPD?
    Hew MJ, Sestini P, Irving LB.
    Med J Aust; 2009 May 04; 190(9):468-9. PubMed ID: 19413514
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
    Gershon A, Croxford R, Calzavara A, To T, Stanbrook MB, Upshur R, Stukel TA.
    JAMA Intern Med; 2013 Jul 08; 173(13):1175-85. PubMed ID: 23689820
    [Abstract] [Full Text] [Related]

  • 20. Contemporary management of chronic obstructive pulmonary disease: scientific review.
    Sin DD, McAlister FA, Man SF, Anthonisen NR.
    JAMA; 2003 Nov 05; 290(17):2301-12. PubMed ID: 14600189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.